[Effectiveness of cephalosporins in experimental anaerobic gas infection].
D000284:Administration, Oral; D000818:Animals; D002506:Cephalexin / Q000494:pharmacology / Q000627:therapeutic use; D002509:Cephaloridine / Q000494:pharmacology / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use; D003013:Clostridium / Q000187:drug effects; D003016:Clostridium perfringens / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005738:Gas Gangrene / Q000188:drug therapy* / Q000382:microbiology; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D051379:Mice; D008826:Microbial Sensitivity Tests; D010400:Penicillin G / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects
D002511:Cephalosporins; D002509:Cephaloridine; D002506:Cephalexin; D010400:Penicillin G; D002512:Cephalothin
Effektivnost' tsefalosporinov pri éksperimental'noĭ anaérobnoĭ infektsii